AIMS: Drug law enforcement remains the dominant response to drug-related harm. However, the impact of incarceration on deterring drug use remains under-evaluated. We sought to explore the relationship between incarceration and patterns of drug use among people who inject drugs (IDU). DESIGN: Using generalized estimating equations (GEE), we examined the prevalence and correlates of injection cessation among participants in the Vancouver Injection Drug User Study followed over 9 years. In subanalyses, we used McNemar's tests and linear growth curve analyses to assess changes in drug use patterns before and after a period of incarceration among participants reporting incarceration and those not incarcerated. FINDINGS: Among 1603 IDU, 842 (53%) reported injection cessation for at least 6 months at some point during follow-up. In multivariate GEE analyses, recent incarceration was associated negatively with injection cessation [adjusted odds ratio (AOR) = 0.43, 95% confidence interval (CI) 0.37-0.50], whereas the use of methadone was associated positively with cessation (AOR = 1.38, 95% CI 1.22-1.56). In subanalyses assessing longitudinal patterns of drug use among incarcerated individuals and those not incarcerated over the study period, linear growth curve analyses indicated that there were no statistically significant differences in patterns of drug use between the two groups (all P > 0.05). CONCLUSIONS: These observational data suggest that incarceration does not reduce drug use among IDU. Incarceration may inhibit access to mechanisms that promote injection cessation among IDU. In contrast, results indicate that methadone use is associated positively with injection cessation, independent of previous frequency of drug use.
AIMS: Drug law enforcement remains the dominant response to drug-related harm. However, the impact of incarceration on deterring drug use remains under-evaluated. We sought to explore the relationship between incarceration and patterns of drug use among people who inject drugs (IDU). DESIGN: Using generalized estimating equations (GEE), we examined the prevalence and correlates of injection cessation among participants in the Vancouver Injection Drug User Study followed over 9 years. In subanalyses, we used McNemar's tests and linear growth curve analyses to assess changes in drug use patterns before and after a period of incarceration among participants reporting incarceration and those not incarcerated. FINDINGS: Among 1603 IDU, 842 (53%) reported injection cessation for at least 6 months at some point during follow-up. In multivariate GEE analyses, recent incarceration was associated negatively with injection cessation [adjusted odds ratio (AOR) = 0.43, 95% confidence interval (CI) 0.37-0.50], whereas the use of methadone was associated positively with cessation (AOR = 1.38, 95% CI 1.22-1.56). In subanalyses assessing longitudinal patterns of drug use among incarcerated individuals and those not incarcerated over the study period, linear growth curve analyses indicated that there were no statistically significant differences in patterns of drug use between the two groups (all P > 0.05). CONCLUSIONS: These observational data suggest that incarceration does not reduce drug use among IDU. Incarceration may inhibit access to mechanisms that promote injection cessation among IDU. In contrast, results indicate that methadone use is associated positively with injection cessation, independent of previous frequency of drug use.
Authors: Will Small; S Kain; Nancy Laliberte; Martin T Schechter; Michael V O'Shaughnessy; Patricia M Spittal Journal: Subst Use Misuse Date: 2005 Impact factor: 2.164
Authors: Nadia Fairbairn; Thomas Kerr; Jane A Buxton; Kathy Li; Julio S Montaner; Evan Wood Journal: Drug Alcohol Depend Date: 2006-12-01 Impact factor: 4.492
Authors: Samuel R Friedman; Enrique R Pouget; Sudip Chatterjee; Charles M Cleland; Barbara Tempalski; Joanne E Brady; Hannah L F Cooper Journal: Am J Public Health Date: 2010-12-16 Impact factor: 9.308
Authors: Hannah L F Cooper; Brooke West; Sabriya Linton; Josalin Hunter-Jones; Maria Zlotorzynska; Ron Stall; Mary E Wolfe; Leslie Williams; H Irene Hall; Charles Cleland; Barbara Tempalski; Samuel R Friedman Journal: Am J Public Health Date: 2015-12-21 Impact factor: 9.308
Authors: Sabriya L Linton; Jacky M Jennings; Carl A Latkin; Marisela B Gomez; Shruti H Mehta Journal: J Urban Health Date: 2014-10 Impact factor: 3.671
Authors: Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral Journal: Lancet HIV Date: 2017-05-14 Impact factor: 12.767